Avantor, Inc. (AVTR): Depreciation & Amortization
$410.20M
Year ended 2025-12-31
$415.50M
Trailing 12 months to 2026-03-31
+0.4%
3-year compound annual growth
+0.7%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $410.20M | +1.2% | 2026-02-11, From 2025-01-01 |
| 2024-12-31 | $405.50M | +0.8% | 2026-02-11, From 2024-01-01 |
| 2023-12-31 | $402.30M | -0.8% | 2026-02-11, From 2023-01-01 |
| 2022-12-31 | $405.50M | +6.9% | 2025-02-07, From 2022-01-01 |
| 2021-12-31 | $379.20M | -4.1% | 2024-02-14, From 2021-01-01 |
| 2020-12-31 | $395.40M | -0.9% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $398.90M | -1.4% | 2022-02-11, From 2019-01-01 |
| 2018-12-31 | $404.60M | +307.9% | 2021-02-16, From 2018-01-01 |
| 2017-12-31 | $99.20M | n/a | 2020-02-14, From 2017-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Avantor, Inc. (AVTR) | 2025-12-31 | $410.20M | +1.2% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $288.00M | +12.1% |
| Illumina, Inc. (ILMN) | 2025-12-28 | $270.00M | -23.7% |
| Bruker Corp (BRKR) | 2025-12-31 | $220.30M | +19.9% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $405.34M | -5.3% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $165.40M | +9.1% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $36.20M | +0.9% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $7.58M | +5.1% |
| Quanterix Corp (QTRX) | 2025-12-31 | $15.84M | +145.1% |
Compare AVTR, A, ILMN, BRKR side by side · Screen every company in Laboratory Analytical Instruments ↗